e8vk
Table of Contents



SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event report): September 17, 2004

AMS HEALTH SCIENCES, INC.

(Exact Name of Registrant as Specified in its Charter)
         
OKLAHOMA
(State or Other
Jurisdiction of
Incorporation or
Organization)
  001-13343
(Commission File
Number)
  73-1323256
(IRS Employer
Identification
Number)

711 NE 39th Street, Oklahoma City, OK 73105
(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code: (405) 842-0131

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o     Soliciting material pursuant to rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))

o     Pre-commencement communications pursuant to rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Information To Be Included in the Report



 


TABLE OF CONTENTS

ITEM 1.01. Entry into a Material Definitive Agreement.
Item 9.01. Financial Statements and Exhibits
SIGNATURES
EXHIBIT INDEX
Press Release


Table of Contents

ITEM 1.01. Entry into a Material Definitive Agreement.

     On September 17, 2004, AMS Health Sciences, Inc. filed a press release announcing the purchase of additional office and warehouse space for a cash price of $525,000. The press release is attached hereto as exhibit 99.1.

Item 9.01. Financial Statements and Exhibits

     (c) Exhibits

99.1  Press release dated September 17, 2004

SIGNATURES

     Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereto duly authorized.

         
  AMS HEALTH SCIENCES, INC.


REGGIE COOK
 
 
  By:   Reggie Cook    
  Chief Financial Officer   
       
 

Date: September 17, 2004

 


Table of Contents

EXHIBIT INDEX

         
Exhibit        
No.
  Description
  Method of Filing
99.1
  Press release dated September 17, 2004   Filed herewith